Advantics - Growth - LAAC

Grow your LAAC programme

ADVANTICS Solutions > Growth > Grow your LAAC programme

Designed to pro-actively flag potential
Left Atrial Appendage Closure (LAAC)
patients within your hospital



Treat more LAAC patients within your hospital through a digital, multi-disciplinary approach helping to protect more patients from Atrial Fibrillation-related stroke.
Grow your programme with ADVANTICSᵀᴹ ClearPath LAAC

Is your organisation ready?

ADVANTICS™ LAAC Solution - Designed to grow your LAAC programme and reduce emergency admissions
using a digital, multidisciplinary approach.

Designed to...

...easily flag potential
LAAC patients

...activate and treat
more patients

...reduce emergency

Explore results


Creating opportunities for growth and delivering complete healthcare pathway

Hospices Civils de Lyon,
HCL, (France)

Case study


Hospices Civils de Lyon (HCL) has been delivering exemplary care for over 200 years. Discover how a collaboration with Boston Scientific helped HCL evolve their LAAC experience, identify potential opportunities, implement a strategy for growth, deliver a complete patient healthcare pathway and achieve their business objectives.
• Increased LAAC procedures more than 2x versus baseline
• Delivered 20% reduction in procedure duration and length of stay
• Increased candidate conversion rate by 35% by expending number of referrers by x4

Read the case study

Pr. Gilles Rioufol - Head of Interventional Cardiology and Hemodynamic, Hospices Civils de Lyon, HCL (France)


“We found in Boston Scientific a real partner to develop our service, combining both deep commitments to work alongside us, and real knowledge about the therapy. Working together on our communication strategy, on patient and referrer activation, on patient flow constraints and on the overall LAAC programme organisation.”

Strengthening the cardiovascular service to support LAAC therapy growth

Sana Klinikum Lichtenberg,
Berlin (Germany)

Case study


Sana Kliniken AG expressed an interest to enhance patient access to LAAC and its clinic service in the Berlin area. Find out how the partnership has driven sustainable results in 18 months:

• 434 potential candidates within 11 months of activity.
• 74% eligible for further screening.
• Growth of the LAAC offering by 1,8x.

Read the case study

Jean Franke - CEO, Sana Klinikum Lichtenberg, Berlin (Germany)


“Working with Boston Scientific has allowed us to expand and professionalize the LAAC program in the cardiology department. Through the collaboration of the clinical team, the IT department and the ADVANTICS team from Boston Scientific, we were able to develop innovative approaches that are now being implemented across the Sana group.”

White Papers – Sana Klinikum Lichtenberg, Berlin (Germany)


Leveraging data mining to identify potential patients for LAAC therapy.

A retrospective analysis of DRG data, based on ICD codes, CHA2DS2-VASc score and severe bleeding in patient history.

Identifying potential patients for LAAC in recurring admissions based on patient history.

Learnings of six months working with a semi-prospective tool.

Video – Sana Klinikum Lichtenberg, Berlin (Germany)


Find out more about the partnership of Sana Klinikum Lichtenberg, Berlin (Germany) and Boston Scientific.

Video interview with Dr. Olaf Göing, Head of Cardiology, Sana Klinikum Lichtenberg, Berlin (Germany).

Video interview with Dr. Olaf Göing, Head of Cardiology, Sana Klinikum Lichtenberg, Berlin, Germany

WATCHMAN FLXTM The One-Time Procedure

The One-Time Procedure

That may provide a long-term
stroke risk reduction in NVAF patients.